Medium-chain acylCoA dehydrogenase (MCAD) deficiency is a disorder of fatty
acid oxidation whose prevalence in North-Eastern Europe has been estimated
at 1/10000 to 1/20000 births. MCAD deficiency can cause sudden death in th
e first two years of life. Two cases in siblings are reported; both patient
s died at nine months of age. Case report: A male infant, born to unrelated
Caucasian parents, died suddenly at age 9 months during an episode of vira
l gastroenteritis. Post mortem examination was non contributive, Twenty-one
months later, his younger sib, aged 9 months, presented with apparently be
nign gastroenteritis causing feeding problems. He was admitted several hour
s later in a coma with severe hypoglycaemia and died shortly afterwards des
pite ressuscitation. Autopsy showed prominent steatosis in the liver. The s
tudy of urinary organic acids and acylcarnitines disclosed pathognomonic pr
ofiles consistent with MCAD. The diagnosis was confirmed by DNA analysis sh
owing the specific MCAD mutation G 985 A in a homozygous state in both sibl
ings. The authors emphasize the value of MCAD routine screening in the newb
orn population, by mutation analysis and/or by blood acylcarnitine profiles
. Conclusion. Screening for MCAD is warranted in all infants presenting wit
h severe malaise or unexplained sudden death.